TABLE 2.
Prevalences of antibiotic resistance among Acinetobacter strains isolated from the sewers at the hospital and the pharmaceutical plant
| Drug | Prevalence (%) of resistance to druga
|
||||||
|---|---|---|---|---|---|---|---|
| Total (n = 385) | Hospital (n = 180)
|
Pharmaceutical plant (n = 205)
|
|||||
| Site A (n = 38) | Site B (n = 78) | Site C (n = 64) | Site A (n = 76) | Site B (n = 72) | Site C (n = 57) | ||
| AM | 13.0 | 2.6 | 2.6 | 3.1 | 10.5 | 26.4b | 31.6 |
| CIP | 0.8 | 0 | 2.6 | 0 | 1.3 | 0 | 0 |
| GE | 6.2 | 0 | 0 | 3.1 | 0 | 20.8c | 12.3 |
| CHL | 36.9 | 55.3 | 16.7d | 26.6 | 25.0 | 51.4b | 61.4 |
| OT | 28.8 | 0 | 37.2b | 12.5e | 5.3 | 48.6b | 61.4 |
| SU | 19.5 | 0 | 2.6 | 4.7 | 0 | 51.4c | 57.9 |
a
n, number of isolates.
b
Statistically significant increase of antibiotic resistance at site B in comparison with site A (P < 0.01).
c
Statistically significant increase of antibiotic resistance at site B in comparison with site A (P < 0.01) (first three sampling times only).
d
Statistically significant decrease of antibiotic resistance at site B in comparison with site A (P < 0.01).
e
Statistically significant decrease of antibiotic resistance at site C in comparison with site B (P < 0.01).